AstraZeneca is paying insitro $40 million upfront to find liver and heart drug targets
Quartz·+2
qz.comInsitro is eligible for up to about $1.46 billion in milestone payments, plus single-digit royalties on global sales
qz.comInsitro is eligible for up to about $1.46 billion in milestone payments, plus single-digit royalties on global sales
Quick actions
Last updated 1 day ago
Last updated 1 day ago